NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults29 Oct 2026
BirlaNu Limited
Analysts/Institutional Investor Meet/Con. Call Updates
BirlaNu Limited has informed the Exchange about the schedule of Investors' Conference Call to discuss the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
BSEBoard MeetingResults29 Oct 2026
Deepak Chemtex Ltd
Deepak Chemtex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Unaudited Financial Results of the Company for the half year ended September 30, 2026
Deepak Chemtex Ltd has scheduled a Board Meeting on November 3, 2026, to consider and approve the unaudited financial results for the half year ended September 30, 2026.
BSECompany Update▲ PositiveResults29 Oct 2026
Strides Pharma Science Ltd
Earnings presentation for the quarter and half year ended September 30, 2026.
Strides Pharma Science Ltd reported a strong Q2FY27 with revenue growth of 17% YoY to ₹14,297m, driven by Ex-US Markets. EBITDA grew 8% YoY to ₹2,509m, despite higher raw material, freight and operating costs. Net Debt increased by ₹2,114m during H1 due to an elongated cash-to-cash cycle and higher inventory holding.
BSEBoard MeetingResults29 Oct 2026
Speedage Commercials Ltd
Speedage Commercials Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve unaudited financial results for the quarter and half year ended 30.09.2026
Speedage Commercials Ltd has scheduled a Board Meeting on November 04, 2026, to consider and approve unaudited financial results for the quarter and half year ended September 30, 2026.
BSECompany UpdateResults29 Oct 2026
Birlanu Ltd
Conference Call to discuss the unaudited standalone and consolidated financial results for Q2 & H1 FY27
Birlanu Ltd has scheduled a conference call on November 3, 2026, to discuss its unaudited standalone and consolidated financial results for Q2 & H1 FY27.
NSEGeneral Updates▲ PositiveResults29 Oct 2026
Strides Pharma Science Limited
General Updates
Strides Pharma Science Limited has announced its Q2 and H1FY27 earnings, with revenue growing 17% YoY to ₹14,297m and ₹26,951m respectively, driven by Ex-US Markets. EBITDA grew 8% YoY to ₹2,509m and ₹4,807m respectively, despite higher raw material, freight and operating costs. Net Debt increased by ₹2,114m during H1 due to an elongated cash-to-cash cycle and higher inventory holding.
BSECompany UpdateResults29 Oct 2026
Indiqube Spaces Ltd
Intimation of Earnings Conference Call on financial performance for the quarter and half year ended September 30, 2026.
Indiqube Spaces Ltd has announced an earnings conference call to discuss its financial performance for the quarter and half year ended September 30, 2026.
BSECompany Update▲ PositiveResults29 Oct 2026
Strides Pharma Science Ltd
Strides Delivers Strong Performance with Q2FY27 Revenue at Rs. 14.297m, Grew 17% YoY.
Ex-US Markets Up 31% YoY; EBITDA Up 8% YoY to Rs. 2,509m, Crossing Rs. 2,500m in a Quarter for the First Time.
Strides Pharma Science Ltd reported Q2FY27 revenue of ₹14,297m, up 17% YoY, driven by Ex-US Markets growth of 31% YoY. EBITDA grew to ₹2,509m, crossing ₹2,500m for the first time, despite higher input material and freight costs.
BSEBoard MeetingResults29 Oct 2026
Ruparel Food Products Ltd
Ruparel Food Products Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Approval of Un-audited (Standalone and Consolidated) Financial Results together with the draft Limited Review Report, Statement of Assets and Liabilities and Statement of Cash
Flows for the quarter and half year ended September 30, 2026.
Ruparel Food Products Ltd has scheduled a board meeting on November 2, 2026, to consider and approve un-audited financial results for the quarter and half year ended September 30, 2026.
NSERecord Date▲ PositiveResults29 Oct 2026
Sanofi India Limited
Record Date
Sanofi India Limited has announced its financial results for the quarter ended September 30, 2026, with a 2% growth in domestic net sales and a 4% growth in total net sales compared to the third quarter of 2025. The company has also declared an interim dividend of Rs. 75 per equity share and fixed November 5, 2026, as the record date for the payment of the dividend.
BSEBoard MeetingResults29 Oct 2026
HMT Ltd
HMT Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Unaudited Standalone And Consolidated Financial Results For Quarter And Half Year Ended 30th September, 2026
HMT Ltd has scheduled a board meeting on November 6, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
BSEBoard MeetingResults29 Oct 2026
IMP Powers Ltd
IMP Powers Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve Pursuant to Regulation 29(1)(a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations,
2015, as amended from time to time, this is to inform you that the Meeting of Board of Directors of the
Company is scheduled to be held on Tuesday, 03rd November, 2026 inter alia, to consider ....
IMP Powers Ltd has scheduled a Board Meeting on 03/11/2026 to consider and approve the Standalone & Consolidated Un-audited Financial Results for the quarter and half year ended on 30/09/2026.
BSEResultResults29 Oct 2026
Deepak Nitrite Ltd-$
Unaudited Financial Result for the quarter and half year ended 30th September, 2026
Deepak Nitrite Ltd has announced its unaudited financial results for the quarter and half year ended 30th September, 2026, with the Board of Directors approving the standalone and consolidated un-audited financial results. The company has enclosed the unaudited financial results and a limited review report issued by its statutory auditors, M/s Deloitte Haskins & Sells LLP.
BSECompany Update▲ PositiveResults29 Oct 2026
Capital Small Finance Bank Ltd
Press Release
Capital Small Finance Bank Ltd reported unaudited financial results for Q2 FY27, with Gross Advances growing 23.4% Y-o-Y to ₹9,755 crore, Total Deposits rising 16.2% Y-o-Y to ₹10,831 crore, and Profit After Tax increasing 30.7% Y-o-Y to ₹45.61 crore.
NSEAnalysts/Institutional Investor Meet/Con. Call UpdatesResults29 Oct 2026
BMW Ventures Limited
Analysts/Institutional Investor Meet/Con. Call Updates
BMW Ventures Limited has scheduled an earnings conference call to discuss its Q2 FY27 financial performance on November 4, 2026, at 1:30 PM IST.
NSEPress Release▲ PositiveResults29 Oct 2026
Sanofi India Limited
Press Release
Sanofi India Limited has announced its Q3 2026 financial results, reporting a 2% growth in domestic net sales and a 4% growth in total net sales compared to the third quarter of 2025. The company's Insulin portfolio delivered a 9% growth in Q3'26, cementing its leadership in the Diabetes Injectable segment with a 55% market share.
BSEBoard MeetingResults29 Oct 2026
Svarnim Trade Udyog Ltd
Svarnim Trade Udyog Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2026 ,inter alia, to consider and approve
1. The Unaudited Financial Results of the Company for the Quarter & half year ended on 30th September, 2026 along with Limited Review Report.
2. Any other matter to be discussed and consider with the permission of Chairperson of the Board Meeting.
Svarnim Trade Udyog Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 03/11/2026 to consider and approve the Unaudited Financial Results for the Quarter & half year ended on 30th September, 2026.
BSECompany Update▲ PositiveResults29 Oct 2026
Capital Small Finance Bank Ltd
Investor Presentation September 30, 2026
Capital Small Finance Bank Ltd has released its unaudited financial results for the period ended September 30, 2026, showing a 7.5% QoQ and 23.4% YoY growth in loan book, 2.2% QoQ and 16.2% YoY growth in deposits, and a 31% YoY growth in profit after tax.
NSEPress Release▲ PositiveResults29 Oct 2026
Capital Small Finance Bank Limited
Press Release
Capital Small Finance Bank Limited has announced its unaudited financial results for the quarter and half year ended September 30, 2026, with Gross Advances increasing to ₹9,755 crore, total Deposits rising to ₹10,831 crore, and Profit After Tax standing at ₹45.61 crore.
NSEUpdatesResults29 Oct 2026
Pidilite Industries Limited
Updates
Pidilite Industries Limited has uploaded the audio recording of its Q2FY27 Earnings Call on its website.